期刊文献+

匹维溴铵治疗腹泻型肠易激综合征的临床观察 被引量:12

The Effect of Pinaverium Bromid on the Patients with Diarrhea Predominant Irritable Bowel Syndrome
原文传递
导出
摘要 目的观察匹维溴铵对腹泻型肠易综合征(IBS)的治疗效果。方法 95例腹泻型肠易激综合征患者接受匹维溴铵治疗2周,观察患者治疗前后腹痛、腹胀、腹泻、大便形态、生活质量改善以及药物副反应。结果接受匹维溴铵治疗2周后,腹泻型lBS患者腹痛、腹胀和腹泻症状评分均较治疗前显著降低(P<0.05),大便性状评分较治疗前下降(P<0.05),生活质量评分较治疗前提高(P<0.05)。但在停药结束后4周上述指标评分较治疗前无明显差异(P>0.05)。结论匹维溴铵可有效缓解腹泻型lBS患者的临床症状,但治疗疗程值得进一步研究。 Objective To investigate the effect of pinaverium bromide on the patients with diarrhea predominant irritable bowel syndrome. Methods 95 patients with diarrhea predominant irritable bowel syndrome were treated with pinaverium bro- mide for two weeks. The abdominal pain, abdominal distension, diarrhea, stool form, quality of life and adverse effect were recor- ded before and after the treatment. Results The score of abdominal pain, abdominal distension and diarrhea of the patients af- ter treatment were obviously lower comparing with prior treatment ( P 〈 0.05 ). The score of bowel form was also lower compa- ring with prior treatment ( P 〈 0.05 ). The score of quality of life of the patients after treatment were significantly higher than that of prior treatment ( P 〈 0.05 ). However, there were no obviously difference between these investigation targets before treat- ment and after stopping treatment for 4 weeks ( P 〉 0.05 ). Conclusion Pinaverium bromide can obviously relieve the symp- toms of diarrhea predominant irritable bowel syndrome,however,the course of treatment need further investigation.
出处 《临床消化病杂志》 2013年第2期82-84,共3页 Chinese Journal of Clinical Gastroenterology
关键词 肠易综合征 匹维溴铵 临床观察 Irritable bowel syndrome Pinaverium bromide Clinical investigation
  • 相关文献

参考文献9

  • 1CHOUNG RS,LOCKE GR 3RD. Epidemiology of IBS[J]. Gastroenterol Clin North Am,2011,40(1):1.
  • 2LIU J, HOU X. A review of the irritable bowel syndrome investigation on epidemiology, pathogenesis and pathophysiology in China [ J ]. J Gastroenterol Hepatol,2011,26( Suppl 3) :88.
  • 3LEE OY. Asian motility studies in irritable bowel syndrome [ J ]. J Neurogastroenterol Motil,2010,16 ( 2 ) : 120.
  • 4DROSSMAN DA, CORAZZIARI E, DELVAUX M, et al. Rome III : The functional gastrointestinal disorders. Third Edition(KS) [ J]. Allen Press, Inc ,2006,492.
  • 5O' DONNELL LJ,VIRJEE J, HEATON KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate [ J ]. BMJ,1990, 300:439.
  • 6KARANTANOS T, MARKOUTSAKI T, GAZOULI M, et al. Current insights in to the pathophysiology of irritable bowel syndrome [ J ]. Gut Pathog,2010,13:2( 1 ) :3.
  • 7WITrMANN T, FEHER A, ROSZTOCZY A, et al. Effectiveness of pinaverium bromide therapy on colonic motility disorders in irritable bowel syndrome [ J ]. Orv Hetil, 1999,140:469.
  • 8姒健敏,陈淑洁,孙蕾民.浙江省肠易激综合征的流行病学和患者生活质量研究[J].中华内科杂志,2003,42(1):34-37. 被引量:50
  • 9余强,张金坤.培菲康和小剂量阿米替林治疗腹泻型肠易激综合征的临床研究[J].航空航天医药,2009,20(1):29-29. 被引量:2

二级参考文献20

  • 1Balsari A, Ceccareli A, Dubini F,et al.The fecal microbial population in the irritable bowel syndrome[J]. Microbiological, 1982,5(3) : 185 - 194
  • 2Comborone J, Dewsnap P, Libby G, et al. Abnormal illness attitube in patients with irritable syndrome. J PsychosomReserve,1995,39(2):227
  • 3Quartero AO, Meiniche - Schmidt V, Muris J, et al. Bulking agents, antis pasmodic and antidepressant medication for the treatment of irritable bowel syndrome.The Cochrane Database of Systematic Reviews.The Cochrane Library, 2002
  • 4Agreus L;Svardsudd K;Nyren O.Irritable bowel syndrome and dyspepsia in the general population:overlap and lack of stability over time[J],1995.
  • 5Harvey RF;Mauad EC;Brown AM.Prognosis in the irritable bowel syndrome: a 5-year prospective study,1987.
  • 6Jones R;Lydeard S.Irritable bowel syndrome in the general population[J],1992.
  • 7Tally NJ;Gabriel SE;Harmsen WS.Medical costs in community subjects with irritable bowel syndrome[J],1995.
  • 8Thompson WG;Longstreth GF;Drossman DA.Functional bowel disorder and functional abdominal pain[J],1999(zk).
  • 9Simren M;Abrahamsson H;Svedlund J.Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern[J],2001(5).
  • 10Schmulson M;Lee OY;Chang L.Symptom differences in moderate to severe IBS patients based on predominant bowel habit[J],1999.

共引文献50

同被引文献100

引证文献12

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部